Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1990 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer.
J Clin Oncol. 2021 Jul 10;39(20):2247-2256. doi: 10.1200/JCO.21.00280. Epub 2021 May 17.
J Clin Oncol. 2021.
PMID: 33999652
Free PMC article.
Clinical Trial.
Squamous cell carcinomas often produce more than a single bone resorption-stimulating factor: role of interleukin-1 alpha*.
Nowak RA, Morrison NE, Goad DL, Gaffney EV, Tashjian AH Jr.
Nowak RA, et al.
Endocrinology. 1990 Dec;127(6):3061-9. doi: 10.1210/endo-127-6-3061.
Endocrinology. 1990.
PMID: 2174344
Several cultured human squamous cell carcinoma cell lines (SCC-4, SCC-12B2, SCC-12F2, EC-GI-10, and BEN) and one normal keratinocyte line (Epy-1) were investigated for the production of bone resorption-stimulating activity (BRSA). ...CM from EC-GI-10, BEN, SCC-4, an …
Several cultured human squamous cell carcinoma cell lines (SCC-4, SCC-12B2, SCC-12F2, EC-GI-10, and BEN) and one normal keratinocyte …
Item in Clipboard
Cite
Cite